Cognitive remediation therapy in schizophrenia: randomised controlled trial
- PMID: 17470957
- DOI: 10.1192/bjp.bp.106.026575
Cognitive remediation therapy in schizophrenia: randomised controlled trial
Abstract
Background: Cognitive difficulties are prevalent in people with a diagnosis of schizophrenia and are associated with poor long-term functioning.
Aims: To evaluate the effectiveness of cognitive remediation therapy on cognitive difficulties experienced by people with schizophrenia.
Method: Participants with a diagnosis of schizophrenia, a social behaviour problem and a cognitive difficulty (n=85) were randomised to 40 sessions of cognitive remediation or treatment as usual in a single-blind randomised controlled trial. Working memory, cognitive flexibility and planning, were measured at weeks 0,14 and 40.
Results: There were durable improvements in working memory (advantage 1.33 points, 95% CI 0.43-2.16, standardised effect size 0.34) as well as an indication of improvement in cognitive flexibility. Memory improvement predicted improvement in social functioning. Costs were lower in the cognitive remediation group following therapy but rose at follow-up. However, cost-effectiveness analyses showed that improvements in memory were achieved at little additional cost.
Conclusions: Cognitive remediation therapy is associated with durable improvements in memory, which in turn are associated with social functioning improvements in people with severe mental illness.
Comment in
-
Cognitive remediation therapy produces moderate improvements in working memory in people with schizophrenia.Evid Based Ment Health. 2008 Feb;11(1):18. doi: 10.1136/ebmh.11.1.18. Evid Based Ment Health. 2008. PMID: 18223053 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
